PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

New partnership gives Chinese customers greater access to Tower Cold Chain containers

Tower Cold Chain has reinforced its global availability by partnering with a Shanghai-based organisation, Tower & Winner Solutions (TWS), to drive the growth of Tower’s temperature-controlled passive containers across the Chinese market.

TWS has been created specifically to provide the local Chinese market with an efficient means to access Tower containers, which are used by pharmaceutical manufacturers, airlines and 3PLs to deliver medicines and life science products wherever they are needed.

“Local representation is critical to delivering the best possible service to our Chinese customers, now and in the future,” said Robert J Paterson, Asia Pacific General Manager.  “By working with TWS, we have the perfect conduit to bring our robust, reliable and reusable solutions to the market.”

TWS will manage all customer communication, business development and local billing.  Tower Cold Chain’s team in the APAC region will work closely with Daniel Liu, Business Development Manager, China for TWS, to develop new customer opportunities.

“We’re looking forward to demonstrating the benefits of Tower products, which are renowned globally for their ability to protect pharmaceutical products during transit,” explained Daniel Liu. “Better still, the reusable system helps customers to achieve a more sustainable supply chain.”

While Tower products are already available from its existing hub in Shanghai, TWS has been tasked to identify new projects, with a view towards opening additional hubs across China in the future.

Commenting on the new partnership, William Chong, Chairman, TWS, said:

“TWS China are very pleased to represent Tower Cold Chain as exclusive GSA in China. We look forward to providing an effective, efficient temperature-controlled packaging solution to the China market.

“With the new GSA agreement in place, TWS and Tower Cold Chain will be able to further breakthrough some of the previous obstacles and further enhance our cooperation for a win-win outcome for both parties in this huge potential China market.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026